Eugene Goldwasser, the biochemist who isolated and purified the anti-anemia protein erythropoietin - arguably the most important biological drug since insulin - died Friday at his home in Chicago of kidney failure associated with prostate cancer. He was 88.

Erythropoietin, commonly known as EPO, was one of the first blockbuster drugs of the biotechnology industry and was the foundation for the success of Amgen of Thousand Oaks, Calif. Yet neither the University of Chicago, where Goldwasser isolated the drug, nor the National Institutes of Health, which funded his work, chose to patent the discovery, and Goldwasser himself never got around to it.

His first wife, Florence, died in 1981. He is survived by his second wife, Deone; three sons, Thomas of San Francisco, Matthew of Chicago and James of New York; two stepchildren; and seven grandchildren.

Urologist sex abuse case … Carcinogens found in West Islip … LIRR's top fare evaders Credit: Newsday

Updated 33 minutes ago Deadly two-car crash in Massapequa Park ... Urologist sex abuse case ... NYS cancels wind farms ... Women softball league

Urologist sex abuse case … Carcinogens found in West Islip … LIRR's top fare evaders Credit: Newsday

Updated 33 minutes ago Deadly two-car crash in Massapequa Park ... Urologist sex abuse case ... NYS cancels wind farms ... Women softball league

Latest Videos

Newsday LogoSUBSCRIBEUnlimited Digital AccessOnly 25¢for 5 months
ACT NOWSALE ENDS SOON | CANCEL ANYTIME